Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-03

FDA Approved: MARLISSA — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves a supplemental application for MARLISSA (levonorgestrel and ethinyl estradiol) submitted by Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MARLISSA (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for MARLISSA (LEVONORGESTREL AND ETHINYL ESTRADIOL)